Research on immunotherapy conducted at the Department of Oncology is presented in a feature article in the popular national Norwegian newspaper Verdens Gang (VG) January 9th. The article focuses on recent progress in chimeric antigen receptor (CAR) T cell therapy. For two years, children with leukemia and adults with lymphoma has been treated through clinical studies. Now the project will be expanded with three new studies on lymphomas.
Published in major journals, first or last author from Oslo University Hospital.
A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply
N Engl J Med, 385 (16), e57
No Strong Evidence on Liver Transplant for Colorectal Cancer Liver Metastasis Over Portal Vein Embolization Associated With Liver Resection-Reply
JAMA Surg (in press)
Urinary Extracellular Vesicles in Urology: Current Successes and Challenges Ahead
Eur Urol (in press)